Damian Garde in STAT Newss:
Scientists have come up with a drug, injected once a day, that appears to make children’s bones grow. To many, it’s a wondrous invention that could improve the lives of thousands of people with dwarfism. To others, it’s a profit-driven solution in search of a problem, one that could unravel decades of hard-won respect for an entire community. In the middle are families, doctors, and a pharmaceutical company, all dealing with a philosophically fraught question: Is it ethical to make a little person taller? The most common cause of dwarfism is known as achondroplasia. People with the condition, caused by a rare genetic mutation, have shorter limbs and shorter stature than those without it, and they deal with a lifetime of skeletal issues that often require a battery of corrective surgeries.
For years a U.S. company called BioMarin Pharmaceutical (BMRN) has been developing a drug that targets the genetic roots of achondroplasia, a mutation that stops cartilage from turning into bone. The goal, according to the company, is to prevent the medical complications associated with achondroplasia, which include sleep apnea, hearing loss, and spinal problems. But proving the drug’s long-term skeletal benefits would require a decades-long study, which is an expensive and, to BioMarin, impractical proposition. Instead, the company is measuring the the most immediate byproduct of bone growth: height. And that’s where the philosophical schism begins. For thousands of little people, the short stature that comes with achondroplasia is not a disability in need of treatment but a difference to be celebrated. Organizations like Little People of America have spent years dispelling stereotypes, advocating for fairness, and pointing out that having achondroplasia doesn’t preclude anyone from a fulfilling life. Dwarf pride means flourishing because of one’s body, not in spite of it.
Through that lens, the drug looks to some like a threat of erasure, a so-called cure for people who are not sick. Furthermore, about 80% of babies with achondroplasia are born to parents of average height. That means, if the drug goes on to win Food and Drug Administration approval, the decision of whether to give it to a child would often be made by people with no exposure to little people culture, who know nothing of dwarf pride. “People feel like this is an effort to eliminate the dwarfism community,” said Becky Curran Kekula, a disability advocate and motivational speaker who was born with achondroplasia.
More here.

The opposite of the jerk is the sweetheart. The sweetheart sees others around him, even strangers, as individually distinctive people with valuable perspectives, whose desires and opinions, interests and goals, are worthy of attention and respect. The sweetheart yields his place in line to the hurried shopper, stops to help the person who has dropped her papers, calls an acquaintance with an embarrassed apology after having been unintentionally rude. In a debate, the sweetheart sees how he might be wrong and the other person right.
Like cosmic hard drives, black holes pack troves of data into compact spaces. But ever since Stephen Hawking
At his first official press conference in 2017, Press Secretary Sean Spicer made a telling choice. After giving the first question to the New York Post, he then called on Jennifer Wishon, who was sitting at the back, in the seventh row. He didn’t mention the news organization she represented, but it was no secret: since 2011 she had served as the White House correspondent for the Christian Broadcasting Network.
Vladimir Nabokov and D. H. Lawrence each wrote a major novel (“Lolita,” “Lady Chatterley’s Lover”) that was banned and unbanned and banned again before being cut free.
As a story-loving child more likely to be found playing detectives than the now-suspect doctors and nurses, I yearned for a family secret. My parents had both been raised with them: in my mother’s case, her dad’s Jewishness was kept hidden from her; in my father’s, paternity remained an unsolved mystery (Pétainist French Catholic priest or local milkman?).
To riff on the opening lines of Steven Shapin’s
Urban Dictionary
The tiny
Changing technologies have always affected how we produce and enjoy art, and music might be the most obvious example. Radio and recordings made it easy for professional music to be widely disseminated, but created a barrier to its creation. Nowadays computers are helping to reverse that trend, allowing casual users to create slick songs of their own. Not everyone is equally good at it, however; Grimes (who currently goes by c, the symbol for the speed of light) is a wildly successful electronic artist who writes, produces, performs, and sings her own songs. We dig into how music is made in the modern world, but also go well beyond that, into artificial intelligence and the nature of digital/virtual/online personae. We talk about the birth of a new digital avatar — who might be called “War Nymph”? — and how to navigate the boundaries of art, technology, fashion, and culture. Her new album 
Lawrence was a mystic, consumed with a vision of each person’s soul as utterly foreign to all others, and yet capable of finding a form of human connection that is so vast that it can contain, as he writes in The Rainbow, “bonds and constraints and labours” and still be “complete liberty.” There is no writer more keenly interested in how men and women relate to one another, or in relatedness as such: the tension between the self—inviolate, contained, individual, isolate—and the couple. He imagined the task of art is the same as the task of life—to be in true relationship to one’s surroundings, in a dynamic flow. He believed the novel was a worthwhile form because in it every part is related to every other. He was a mystic seeking absolute truth, which now seems passé, and precious. His voice is as heady and vague as it is pure and urgent, and even his “worst pages,” as his contemporary Catherine Carswell wrote, “dance with life that could be mistaken for no other man’s.”
“Latin America doesn’t matter,” President Nixon told his advisors in 1973. “People don’t give a shit about the place.” Secretary of State Henry Kissinger agreed, saying “what happens in the south has no importance.” That same year, Arana writes, “Kissinger received concrete evidence of the massacres,” but “stated that ‘however unpleasant’ these circumstances might be, the overall situation was beneficial to the United States.” As he told the Argentine foreign minister as the killing was happening, “We want you to succeed.”
IN 1971, AFTER THE UNITED STATES
On 15 June 2017, scientists at a respected biological institute in Germany were thrown into crisis by an alarming announcement. An investigation into the Leibniz Institute on Aging had found that its director, cell biologist Karl Lenhard Rudolph, had
Beginning in 1991,